Bachelor of Veterinary Science and Animal Husbandry degree from Bombay Veterinary College, India.
Working Experience
Dr Fong has thirty seven (37) years of industry experience. He held several job portfolios during his employment with Pfizer - Malaysia. Dr Fong joined Pfizer as Veterinary Promotions Manager in 1981. Throughout seven (7) years of serving the domestic market in Malaysia, he held positions as Product Manager, National Sales Manager and Feedmill Marketing Manager. Dr Fong was posted to Thailand as the Business Manager of Pfizer Thailand Ltd for three (3) years from 1988 to 1990. His responsibilities included running the animal health business of Pfizer Thailand, and a premix plant, product formulation, product quality control, and development of product stability. He was promoted to the position of Regional Director of Sales for Association of South East Asia Nation (ASEAN) countries in 1991. He was also in charge of business development for Pfizer in China, Hong Kong and Sri Lanka. When Pfizer acquired the worldwide animal health business of SmithKline Beecham, he was specifically in charge of the acquisition and problem solving activities in the Philippines from 1994 to 1996. In 1998, Dr Fong together with the existing management of Pfizer in Malaysia, established Sunzen Corporation Sdn. Bhd. ("Sunzen Corporation") to undertake a management buy-out of Pfizers local distribution and marketing operations. In 2001, Dr Fong left Sunzen Corporation to join Phibro Animal Health Inc, USA as Regional Director for ASEAN countries and as Managing Director of their local incorporated company, Phibro Malaysia Sdn Bhd. He rejoined Sunzen Corporation in 2002 and appointed as an Executive Director of Sunzen Biotech Berhad on 25 April 2008 and subsequently resigned on 18 July 2014.
Interest
Details of interest held in Sunzen Biotech Berhad:- Ordinary Shares Direct - 2,131,290 Indirect - Nil Warrants 2022/2027 Direct - 1,065,645 Indirect - Nil
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....